S. Seeber

German Cancer Research Center — Germany

Medicine · Health Sciences

13h-index582citations110works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Treatment and Pharmacology(25), Lung Cancer Treatments and Mutations(22), Colorectal Cancer Treatments and Studies(21), Gastric Cancer Management and Outcomes(9), Lung Cancer Diagnosis and Treatment(8)

Publications110 total

A dynamic anthropomorphic phantom for end‐to‐end testing in image‐ and surface‐guided adaptive radiotherapy
Medical Physics·2025Open Access
An abdominal phantom with anthropomorphic organ motion and multimodal imaging contrast for MR-guided radiotherapy
Physics in Medicine and Biology·2022· 15 cited
PO-1600: Evaluation of a High Dynamic Multileaf Collimator for Real-Time tumor tracking
Radiotherapy and Oncology·2020
Long-term survival (LTS) and competing risks within a prospective multi center German randomized trial comparing induction chemotherapy (CTx) followed by concurrent (cc) chemoradiation (CTx/RTx) plus surgery (SURG; TRIMODALITY) supplemented by PCI versus local treatment (Tx) alone (SURG + RTx) in operable IIIA NSCLC.
Journal of Clinical Oncology·2011
Kombinierte Chemo- und Radiotherapie bei inoperablem kleinzellig-anaplastischem Bronchialkarzinom: Verlaufsanalyse bei 50 Patienten<sup>*</sup> <sup>1</sup>
DMW - Deutsche Medizinische Wochenschrift·2008· 5 cited
Levonantradol bei der Behandlung von zytostatika-bedingter Übelkeit und Erbrechen: Klinische Erfahrungen
DMW - Deutsche Medizinische Wochenschrift·2008· 11 cited
Chemotherapie der fortgeschrittenen Lymphogranulomatose: Ergebnisse der MOPP/COPP-Behandlung am Westdeutschen Tumorzentrum Essen
DMW - Deutsche Medizinische Wochenschrift·2008· 6 cited
6608 POSTER An expanded access clinical program of erlotinib in patients (pts) with advanced stage IIIb/ IV non-small-cell lung cancer (NSCLC) – an update of a single institution experience
European Journal of Cancer Supplements·2007
Der Adnatest® als Kontrolle eines Therapieansprechens im Blut bei Patientinnen mit metastasiertem Mammakarzinom
Senologie - Zeitschrift für Mammadiagnostik und -therapie·2007
Phase I Study of a Weekly Schedule of Infusional 5-Fluorouracil/Leucovorin and Irinotecan in Combination with Escalating Doses of Biweekly Cisplatin as First-Line Chemotherapy for Advanced Gastric Cancer
TumorDiagnostik & Therapie·2006
P-067 Impact of mismatch repair protein expression on cisplatinum-basedchemotherapeutic response in patients with stage III non-small-cell lung cancer (NSCLC)
Lung Cancer·2005
O-034 Preoperative chemotherapy and concurrent radio-chemotherapyfollowed by definitive surgery (“Trimodality”) in patients with locally advanced inoperable non-small-cell lung cancer stage IIIA/IIIB — 10-year-survival results
Lung Cancer·2005· 1 cited
Phase I/II study of PTK787/ZK 222584 (PTK/ZK), a novel, oral angiogenesis inhibitor in combination with FOLFIRI as first-line treatment for patients with metastatic colorectal cancer (CRC)
Journal of Clinical Oncology·2005· 53 cited
Phase I study of the humanized anti-epidermal growth factor receptor (EGFR) antibody EMD 72000 (matuzumab) in combination with cisplatin, 5-fluorouracil and leucovorin (PFL) in patients (pts) with advanced esophago-gastric (EG) adenocarcinoma
Journal of Clinical Oncology·2005· 8 cited
Long-term results of stage III and IV ovarian carcinoma treatment
Journal of Clinical Oncology·2005
Pharmacokinetics of treosulfan in a myeloablative combination with cyclophosphamide prior to allogeneic hematopoietic stem cell transplantation
International Journal of Clinical Pharmacology and Therapeutics·2004· 8 cited
Ernährung, Lifestyle und Krebs: Wege zur Primärprävention
DMW - Deutsche Medizinische Wochenschrift·2004· 2 cited
Randomized phase III trial in locally advanced squamous cell carcinoma of the esophagus: Neoadjuvant radiochemotherapy followed by surgery vs. definitive radiochemotherapy
International Journal of Radiation Oncology*Biology*Physics·2004· 1 cited
Phase I/II study of PTK787/ZK 222584 (PTK/ZK), a novel, oral angiogenesis inhibitor in combination with FOLFIRI as first-line treatment for patients with metastatic colorectal cancer
Journal of Clinical Oncology·2004· 9 cited
A randomized phase I study of the humanized anti-epidermal growth factor receptor (EGFR) monoclonal antibody EMD 72000 in subjects with advanced gastrointestinal cancers
Journal of Clinical Oncology·2004· 5 cited
page 1 of 6Next →

Frequent Co-authors

Dirk Strumberg(11), A. Harstrick(11), U. Vanhoefer(10), U. Klaassen(9), M. E. Scheulen(9), N. Schleucher(7), Tanja Trarbach(6), Hans‐Joachim Wilke(6), Heike Richly(5), P. Kupsch(5), Ralf A. Hilger(5), H. Wilke(5), C. G. Schmidt(5), Wilfried Eberhardt(5), R. Becher(4), K. Passarge(4), Catherine G. Haase(4), Brian Schwartz(4), K. Diergarten(4), Mitra Tewes(3)